Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A36154 | 18923878 | Obes Surg | Pattern of expression of adiponectin receptors in human liver and its relation to nonalcoholic steatohepatitis. | 2008 | Details |
| A36213 | 18720537 | World J Gastroenterol | Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis. | 2008 | Details |
| A36230 | 18681440 | J Agric Food Chem | Protective effects of dietary chamomile tea on diabetic complications. | 2008 | Details |
| A36431 | 18226970 | Surg Obes Relat Dis | Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated? | 2008 | Details |
| A36453 | 18178283 | Diabetes Res Clin Pract | Association of elevated alanine aminotransferase with BMI and diabetes in older veteran outpatients. | 2008 | Details |
| A36556 | 17852839 | Scand J Gastroenterol | Incidence rates and causes of cirrhosis in a Norwegian population. | 2007 | Details |
| A36584 | 17680648 | Hepatology | HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis. | 2007 | Details |
| A36620 | 17599864 | Endocr Pract | The multifaceted associations of hepatobiliary disease and diabetes. | 2007 | Details |
| A36639 | 17547834 | Curr Diab Rep | NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes. | 2007 | Details |
| A36648 | 17530362 | J Gastroenterol | Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage. | 2007 | Details |
| A36672 | 17483780 | Gastroenterol Clin Biol | [Steatosis, chronic hepatitis virus C infection and homocysteine]. | 2007 | Details |
| A36719 | 17392582 | Mediators Inflamm | Serum adipokine and ghrelin levels in nonalcoholic steatohepatitis. | 2006 | Details |
| A36801 | 17241878 | Gastroenterology | Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. | 2006 | Details |
| A36893 | 16988759 | J Gastroenterol | Clinical features of nonalcoholic steatohepatitis in Japan: Evidence from the literature. | 2006 | Details |
| A36911 | 16958001 | Dig Dis Sci | Predictors of cirrhosis in Hispanic patients with nonalcoholic steatohepatitis. | 2006 | Details |
| A36914 | 16952548 | Gastroenterology | Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. | 2006 | Details |
| A36955 | 16868265 | Psychosom Med | Depression, anxiety, and nonalcoholic steatohepatitis. | 2008 | Details |
| A36979 | 16790033 | Am J Gastroenterol | The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH. | 2006 | Details |
| A36988 | 16768126 | Nihon Rinsho | [NASH and metabolic syndrome]. | 2006 | Details |
| A36992 | 16768116 | Nihon Rinsho | [Drug-induced NASH]. | 2006 | Details |
| A37058 | 16554999 | Surg Today | Hepatocellular carcinoma arising from nonalcoholic steatohepatitis: report of two cases. | 2006 | Details |
| A37062 | 16540767 | J Clin Gastroenterol | Bariatric surgery: a promising solution for nonalcoholic steatohepatitis in the very obese. | 2006 | Details |
| A37068 | 16531962 | Ann Hepatol | Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis. | 2006 | Details |
| A37081 | 16672825 | J Clin Gastroenterol | Bariatric Surgery: A Promising Solution for Nonalcoholic Steatohepatitis in the Very Obese. | 2006 | Details |
| A37143 | 16385240 | Alcohol Clin Exp Res | Clinical significance of soluble TNF receptor in Japanese patients with non-alcoholic steatohepatitis. | 2005 | Details |
| A37144 | 16385236 | Alcohol Clin Exp Res | Comparison of liver histology between patients with non-alcoholic steatohepatitis and patients with alcoholic steatohepatitis in Japan. | 2005 | Details |
| A37187 | 16297361 | J Investig Med | Peroxisome proliferator-activated receptor alpha L162V polymorphism in nonalcoholic steatohepatitis and genotype 1 hepatitis C virus-related liver steatosis. | 2005 | Details |
| A37236 | 16201069 | Hepatogastroenterology | Nateglinide is useful for nonalcoholic steatohepatitis (NASH) patients with type 2 diabetes. | 2005 | Details |
| A37255 | 16157983 | Intern Med | Type 2 diabetes mellitus complicated with smoldering myeloma and non-alcoholic steatohepatitis. | 2005 | Details |
| A37260 | 16133366 | Virchows Arch | Hepatocellular carcinoma and nonalcoholic steatohepatitis developing during long-term administration of valproic acid. | 2005 | Details |
| A37262 | 16117721 | Dis Manag | Use of chromium picolinate and biotin in the management of type 2 diabetes: an economic analysis. | 2005 | Details |
| A37277 | 16083157 | J Med Assoc Thai | The prevalence of nonalcoholic steatohepatitis in Thai patients with non-HBV, non-HCV chronic hepatitis. | 2004 | Details |
| A37369 | 15842583 | Am J Gastroenterol | Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C. | 2005 | Details |
| A37385 | 15800693 | Rom J Gastroenterol | The emerging problem of nonalcoholic steatohepatitis (NASH). | 2005 | Details |
| A37462 | 19861844 | Saudi J Gastroenterol | Angiogenic effects of leptin in patients with nonalcoholic steatohepatitis. | 2005 | Details |
| A37472 | 15605307 | Semin Liver Dis | Hepatotoxicity of drugs used for treatment of obesity and its comorbidities. | 2004 | Details |
| A37484 | 15580405 | J Gastroenterol | Nonalcoholic steatohepatitis associated with psoriasis vulgaris. | 2004 | Details |
| A37499 | 15554595 | Neth J Med | Nonalcoholic steatohepatitis. | 2004 | Details |
| A37505 | 15527633 | Obes Surg | Factors determining conversion from laparoscopic to open Roux-en-Y gastric bypass. | 2004 | Details |
| A37549 | 15447754 | Am J Gastroenterol | Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. | 2004 | Details |
| A37598 | 15303464 | Trop Gastroenterol | Prevalence of obesity, diabetes mellitus and hyperlipidaemia in patients with cryptogenic liver cirrhosis. | 2004 | Details |
| A37620 | 15256362 | Am J Physiol Gastrointest Liver Physiol | Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. | 2004 | Details |
| A37650 | 15190393 | Can J Gastroenterol | Clinical presentation and prevalence of spontaneous bacterial peritonitis in patients with cryptogenic cirrhosis and features of metabolic syndrome. | 2004 | Details |
| A37665 | 15168253 | J Gastroenterol | Hepatocellular carcinoma with nonalcoholic steatohepatitis. | 2004 | Details |
| A37704 | 15078477 | Liver Int | Clinical and histopathological features of NASH in workers exposed to chemicals with or without associated metabolic conditions. | 2004 | Details |
| A37718 | 15047754 | J Clin Pathol | A tale of two sisters. | 2004 | Details |
| A37720 | 15046220 | Am J Gastroenterol | Ethnic differences in the prevalence of cryptogenic cirrhosis. | 2004 | Details |
| A37770 | 14697954 | Transplant Proc | Outcomes of liver transplantation for cryptogenic cirrhosis: a single-center study of 71 patients. | 2003 | Details |
| A37807 | 14609874 | Arch Surg | Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. | 2003 | Details |
| A37839 | 14506393 | J Clin Gastroenterol | Is hypothyroidism a risk factor for non-alcoholic steatohepatitis? | 2003 | Details |
| A37868 | 12907343 | Am J Gastroenterol | Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis. | 2003 | Details |
| A37895 | 12836490 | Acta Clin Belg | Nonalcoholic steatohepatitis and insulin resistance: interface between gastroenterologists and endocrinologists. | 2003 | Details |
| A37954 | 12687723 | Nihon Arukoru Yakubutsu Igakkai Zasshi | Clinical and pathological differences between alcoholic hepatitis and non-alcoholic steatohepatitis. | 2003 | Details |
| A37997 | 12541180 | Z Gastroenterol | [NASH -- nonalcoholic steatohepatitis]. | 2003 | Details |
| A38021 | 12479942 | Hepatol Res | Nonalcoholic steatohepatitis: risk factors for liver fibrosis. | 2002 | Details |
| A38041 | 12425538 | Am J Gastroenterol | Nonalcoholic steatohepatitis: what we know in the new millennium. | 2002 | Details |
| A38064 | 12358265 | Am J Gastroenterol | Contribution of obesity to hepatitis C-related fibrosis progression. | 2002 | Details |
| A38077 | 12214337 | Rev Gastroenterol Mex | [Treatment of non-alcoholic steatohepatitis (NASH). A comparative study of ursodeoxycholic acid and alpha-tocopherol. A preliminary report]. | 2002 | Details |
| A38082 | 12198667 | Hepatology | Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol. | 2002 | Details |
| A38085 | 12192203 | J Clin Gastroenterol | Management of nonalcoholic steatohepatitis: an analytic review. | 2002 | Details |
| A38104 | 12138383 | Rev Gastroenterol Peru | [NASH: REPORT OF THE FIRST CASES AT THE GUILLERMO ALMENARA HOSPITAL] | 2019 | Details |
| A38122 | 12094872 | Am J Gastroenterol | Is NASH underdiagnosed among African Americans? | 2002 | Details |
| A38126 | 12085358 | Hepatology | HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. | 2002 | Details |
| A38130 | 12076877 | J Hepatol | Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. | 2002 | Details |
| A38149 | 12045779 | Can J Gastroenterol | Nonalcoholic steatohepatitis in nondiabetic obese patients. | 2002 | Details |
| A38179 | 11965828 | Int J Clin Pract Suppl | Thiazolidinedione hepatotoxicity: a class effect? | 2000 | Details |
| A38186 | 11944630 | Semin Gastrointest Dis | Diabetes mellitus, obesity, and hepatic steatosis. | 2002 | Details |
| A38220 | 11873108 | J Clin Gastroenterol | Update on nonalcoholic fatty liver disease. | 2002 | Details |
| A38221 | 11870378 | Hepatology | Risk factors of fibrosis in alcohol-induced liver disease. | 2002 | Details |
| A38231 | 11826411 | Hepatology | NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. | 2002 | Details |
| A38233 | 11825539 | Curr Gastroenterol Rep | Evolving pathophysiologic concepts in nonalcoholic steatohepatitis. | 2002 | Details |
| A38248 | 11768156 | Lipids | Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients. | 2001 | Details |
| A38311 | 11584370 | Hepatology | High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. | 2001 | Details |
| A38328 | 11552214 | Liver Transpl | Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease. | 2001 | Details |
| A38334 | 11522755 | Gastroenterology | Nonalcoholic steatohepatitis. | 2001 | Details |
| A38357 | 11454190 | Liver | Chronic hepatitis C and superimposed nonalcoholic fatty liver disease. | 2001 | Details |
| A38390 | 11374713 | Am J Gastroenterol | Severe cholestatic hepatitis from troglitazone in a patient with nonalcoholic steatohepatitis and diabetes mellitus. | 2001 | Details |
| A38395 | 11349722 | Transplantation | Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation. | 2001 | Details |
| A38442 | 11232700 | Am J Gastroenterol | A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis. | 2001 | Details |
| A38466 | 11169153 | Pathol Int | Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. | 2001 | Details |
| A38546 | 11003611 | Hepatology | Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. | 2000 | Details |
| A38659 | 10634920 | Clin Nutr | Non-alcoholic fatty liver: another feature of the metabolic syndrome? | 1999 | Details |
| A38689 | 10573511 | Hepatology | Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. | 1999 | Details |
| A38796 | 10051466 | Hepatology | Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. | 1999 | Details |
| A39043 | 9195388 | J Gastroenterol Hepatol | Review: nonalcoholic steatohepatitis. | 1997 | Details |
| A39104 | 8990367 | Transplantation | Recurrence of nonalcoholic steatohepatitis following liver transplantation. | 1996 | Details |
| A40846 | 6878882 | Res Vet Sci | Isoenzymes of canine plasma alkaline phosphatase: an investigation using isoelectric focusing and related to diagnosis. | 1983 | Details |
| A42214 | 35199660 | Curr Opin Clin Nutr Metab Care | Maternal weight and gestational diabetes impacts on child health. | 2022 | Details |
| A42269 | 35039631 | Cell Mol Immunol | Neutrophils in chronic inflammatory diseases. | 2022 | Details |
| A42284 | 34986261 | Diabetes Care | Response to Comment on Parente et al. The Relationship Between Body Fat Distribution and Nonalcoholic Fatty Liver in Adults With Type 1 Diabetes. Diabetes Care 2021;44:1706-1713. | 2022 | Details |
| A42285 | 34986259 | Diabetes Care | Comment on Parente et al. The Relationship Between Body Fat Distribution and Nonalcoholic Fatty Liver in Adults With Type 1 Diabetes. Diabetes Care 2021;44:1706-1713. | 2022 | Details |
| A42293 | 34944764 | Biomedicines | The Change in Metabolic Syndrome Status and the Risk of Nonviral Liver Cirrhosis. | 2021 | Details |
| A42309 | 34911389 | J Investig Med High Impact Case Rep | Overlap of Psoriatic Arthritis and Dermatomyositis. | 2021 | Details |
| A42321 | 34875311 | J Hepatol | Arabic Association for the Study of Diabetes and Metabolism (AASD) endorsing the MAFLD definition of fatty liver disease. | 2021 | Details |
| A42322 | 34871785 | Ann Hepatol | Glycemic control, the unconsidered outcome in the treatment of nonalcoholic fatty liver disease. | 2021 | Details |
| A42332 | 34847647 | Diabetes Metab J | Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707). | 2021 | Details |
| A42333 | 34847645 | Diabetes Metab J | Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707). | 2021 | Details |
| A42337 | 34825869 | Curr Drug Metab | Regulatory Effects of N-3 PUFAs on Pancreatic β-cells and Insulin-sensitive Tissues. | 2021 | Details |
| A42364 | 34760761 | J Family Med Prim Care | Nonalcoholic fatty liver disease in lean and obese patients in Saudi patients from a single center. | 2021 | Details |
| A42371 | 34741327 | Aliment Pharmacol Ther | Editorial: evolution of GLP-1 receptor agonists as pharmacotherapy for NASH beyond diabetes mellitus and obesity - authors' reply. | 2021 | Details |